Impax Says Investors' Drug Price-Fixing Suit Still Fails
Impax Laboratories has asked a California federal judge to again quash investors' attempt to revive claims that the generic-drug manufacturer hid news of a federal investigation into whether it was colluding...To view the full article, register now.
Already a subscriber? Click here to view full article